<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38612641</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Microfluidic Isolation of Neuronal-Enriched Extracellular Vesicles Shows Distinct and Common Neurological Proteins in Long COVID, HIV Infection and Alzheimer's Disease.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3830</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25073830</ELocationID><Abstract><AbstractText>Long COVID (LongC) is associated with a myriad of symptoms including cognitive impairment. We reported at the beginning of the COVID-19 pandemic that neuronal-enriched or L1CAM+ extracellular vesicles (nEVs) from people with LongC contained proteins associated with Alzheimer's disease (AD). Since that time, a subset of people with prior COVID infection continue to report neurological problems more than three months after infection. Blood markers to better characterize LongC are elusive. To further identify neuronal proteins associated with LongC, we maximized the number of nEVs isolated from plasma by developing a hybrid EV Microfluidic Affinity Purification (EV-MAP) technique. We isolated nEVs from people with LongC and neurological complaints, AD, and HIV infection with mild cognitive impairment. Using the OLINK platform that assesses 384 neurological proteins, we identified 11 significant proteins increased in LongC and 2 decreased (BST1, GGT1). Fourteen proteins were increased in AD and forty proteins associated with HIV cognitive impairment were elevated with one decreased (IVD). One common protein (BST1) was decreased in LongC and increased in HIV. Six proteins (MIF, ENO1, MESD, NUDT5, TNFSF14 and FYB1) were expressed in both LongC and AD and no proteins were common to HIV and AD. This study begins to identify differences and similarities in the neuronal response to LongC versus AD and HIV infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pulliam</LastName><ForeName>Lynn</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, San Francisco VA Health Care System, San Francisco, CA 94121, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, San Francisco VA Health Care System, San Francisco, CA 94121, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCafferty</LastName><ForeName>Erin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, San Francisco VA Health Care System, San Francisco, CA 94121, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soper</LastName><ForeName>Steven A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Chemistry, The University of Kansas, Lawrence, KS 66045, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of BioModular Multiscale Systems for Precision Medicine, The University of Kansas, Lawrence, KS 66045, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Biology, The University of Kansas Medical Center, Kansas City, KS 66103, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioengineering Program, The University of Kansas, Lawrence, KS 66045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witek</LastName><ForeName>Malgorzata A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Chemistry, The University of Kansas, Lawrence, KS 66045, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of BioModular Multiscale Systems for Precision Medicine, The University of Kansas, Lawrence, KS 66045, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Biology, The University of Kansas Medical Center, Kansas City, KS 66103, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Mengjia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cancer Biology, The University of Kansas Medical Center, Kansas City, KS 66103, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Judith M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Mental Health, San Francisco VA Health Care System, San Francisco, CA 94121, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Mental Health, San Francisco VA Health Care System, San Francisco, CA 94121, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapogiannis</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2181-3118</Identifier><AffiliationInfo><Affiliation>Laboratory of Clinical Investigation, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glesby</LastName><ForeName>Marshall J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-2145-148X</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Weill Cornell Medical College, New York City, NY 10021, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merenstein</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, Georgetown University School of Medicine, Washington, DC 20007, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tien</LastName><ForeName>Phyllis C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, San Francisco VA Health Care System, San Francisco, CA 94121, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freasier</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>French</LastName><ForeName>Audrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Cook County Health, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKay</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Monica M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0001-9663-5948</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ofotokun</LastName><ForeName>Igho</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lake</LastName><ForeName>Jordan E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margolick</LastName><ForeName>Joseph B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Eun-Young</ForeName><Initials>EY</Initials><Identifier Source="ORCID">0000-0002-7436-7396</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levine</LastName><ForeName>Steven R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Neurology, State University of New York College of Medicine and Downstate Medical Sciences University, Brooklyn, NY 11203, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischl</LastName><ForeName>Margaret A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Miami, Miami, FL 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Clinical and Diagnostic Sciences, University of Alabama, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinson</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15260, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Norina</ForeName><Initials>N</Initials><Identifier Source="ORCID">0009-0002-3485-1762</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, San Francisco VA Health Care System, San Francisco, CA 94121, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 HL146245</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH121121</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL146208</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001409</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>KL2 TR001432</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL146192</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL146242</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>TL1 TR001431</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 CX002322</GrantID><Acronym>CX</Acronym><Agency>CSRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>P41 EB020594</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL146194</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL146241</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AI027767</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AI050409</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL146333</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL146205</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 MH116867</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AI073961</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL146201</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 GM130423</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>IK6 CX002519</GrantID><Acronym>CX</Acronym><Agency>CSRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL146193</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL146204</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL146202</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001881</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000004</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL146240</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL146203</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003098</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AI050410</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044085" MajorTopicYN="N">Microfluidics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="Y">Extracellular Vesicles</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">L1CAM</Keyword><Keyword MajorTopicYN="N">OLINK</Keyword><Keyword MajorTopicYN="N">extracellular vesicles</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">microfluidics</Keyword></KeywordList><CoiStatement>S.A.S. has equity in and is on the Board of Directors of BioFluidica, Inc., a company that commercializes EV-MAP. M.A.W. is a spouse of an employee of BioFluidica. Other authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>13</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>13</Day><Hour>1</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38612641</ArticleId><ArticleId IdType="pmc">PMC11011771</ArticleId><ArticleId IdType="doi">10.3390/ijms25073830</ArticleId><ArticleId IdType="pii">ijms25073830</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker J.H., Lin J.J., Doernberg M., Stone K., Navis A., Festa J.R., Wisnivesky J.P. Assessment of Cognitive Function in Patients After COVID-19 Infection. JAMA Netw. Open. 2021;4:e2130645. doi: 10.1001/jamanetworkopen.2021.30645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.30645</ArticleId><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Giraldo G.S., Ali S.T., Kang A.K., Patel T.R., Budhiraja S., Gaelen J.I., Lank G.K., Clark J.R., Mukherjee S., Singer T., et al. Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity. Ann. Neurol. 2023;94:146&#x2013;159. doi: 10.1002/ana.26649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26649</ArticleId><ArticleId IdType="pmc">PMC10724021</ArticleId><ArticleId IdType="pubmed">36966460</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford N.D., Agedew A., Dalton A.F., Singleton J., Perrine C.G., Saydah S. Notes from the Field: Long COVID Prevalence Among Adults&#x2014;United States, 2022. MMWR Morb. Mortal. Wkly. Rep. 2024;73:135&#x2013;136. doi: 10.15585/mmwr.mm7306a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7306a4</ArticleId><ArticleId IdType="pmc">PMC10899083</ArticleId><ArticleId IdType="pubmed">38359012</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Bae S., Chang H.H., Kim S.W. Long COVID prevalence and impact on quality of life 2 years after acute COVID-19. Sci. Rep. 2023;13:11207. doi: 10.1038/s41598-023-36995-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-36995-4</ArticleId><ArticleId IdType="pmc">PMC10336045</ArticleId><ArticleId IdType="pubmed">37433819</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Bae S., Chang H.-H., Kim S.-W. Characteristics of long COVID and the impact of COVID-19 vaccination on long COVID 2 years following COVID-19 infection: Prospective cohort study. Sci. Rep. 2024;14:854. doi: 10.1038/s41598-023-50024-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-50024-4</ArticleId><ArticleId IdType="pmc">PMC10774352</ArticleId><ArticleId IdType="pubmed">38191556</ArticleId></ArticleIdList></Reference><Reference><Citation>Amadoro G., Latina V., Stigliano E., Micera A. COVID-19 and Alzheimer&#x2019;s Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future. Cells. 2023;12:2601. doi: 10.3390/cells12222601.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12222601</ArticleId><ArticleId IdType="pmc">PMC10670749</ArticleId><ArticleId IdType="pubmed">37998336</ArticleId></ArticleIdList></Reference><Reference><Citation>Abubakar M.B., Sanusi K.O., Ugusman A., Mohamed W., Kamal H., Ibrahim N.H., Khoo C.S., Kumar J. Alzheimer&#x2019;s Disease: An Update and Insights Into Pathophysiology. Front. Aging Neurosci. 2022;14:742408. doi: 10.3389/fnagi.2022.742408.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.742408</ArticleId><ArticleId IdType="pmc">PMC9006951</ArticleId><ArticleId IdType="pubmed">35431894</ArticleId></ArticleIdList></Reference><Reference><Citation>2023 Alzheimer&#x2019;s disease facts and figures. Alzheimers Dement. 2023;19:1598&#x2013;1695. doi: 10.1002/alz.13016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.13016</ArticleId><ArticleId IdType="pubmed">36918389</ArticleId></ArticleIdList></Reference><Reference><Citation>Nightingale S., Ances B., Cinque P., Dravid A., Dreyer A.J., Gissl&#xe9;n M., Joska J.A., Kwasa J., Meyer A.-C., Mpongo N., et al. Cognitive impairment in people living with HIV: Consensus recommendations for a new approach. Nat. Rev. Neurol. 2023;19:424&#x2013;433. doi: 10.1038/s41582-023-00813-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-023-00813-2</ArticleId><ArticleId IdType="pubmed">37311873</ArticleId></ArticleIdList></Reference><Reference><Citation>Winston C.N., Goetzl E.J., Akers J.C., Carter B.S., Rockenstein E.M., Galasko D., Masliah E., Rissman R.A. Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile. Alzheimer&#x2019;s Dement. Diagn. Assess. Dis. Monit. 2016;3:63&#x2013;72. doi: 10.1016/j.dadm.2016.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dadm.2016.04.001</ArticleId><ArticleId IdType="pmc">PMC4925777</ArticleId><ArticleId IdType="pubmed">27408937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapogiannis D., Mustapic M., Shardell M.D., Berkowitz S.T., Diehl T.C., Spangler R.D., Tran J., Lazaropoulos M.P., Chawla S., Gulyani S., et al. Association of Extracellular Vesicle Biomarkers with Alzheimer Disease in the Baltimore Longitudinal Study of Aging. JAMA Neurol. 2019;76:1340&#x2013;1351. doi: 10.1001/jamaneurol.2019.2462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.2462</ArticleId><ArticleId IdType="pmc">PMC6632160</ArticleId><ArticleId IdType="pubmed">31305918</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortimer J.A., French L.R., Hutton J.T., Schuman L.M. Head injury as a risk factor for Alzheimer&#x2019;s disease. Neurology. 1985;35:264&#x2013;267. doi: 10.1212/WNL.35.2.264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.35.2.264</ArticleId><ArticleId IdType="pubmed">3969219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Cejudo J., Wisniewski T., Marmar C., Zetterberg H., Blennow K., de Leon M.J., Fossati S. Traumatic Brain Injury and Alzheimer&#x2019;s Disease: The Cerebrovascular Link. EBioMedicine. 2018;28:21&#x2013;30. doi: 10.1016/j.ebiom.2018.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.01.021</ArticleId><ArticleId IdType="pmc">PMC5835563</ArticleId><ArticleId IdType="pubmed">29396300</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry D.C., Sturm V.E., Peterson M.J., Pieper C.F., Bullock T., Boeve B.F., Miller B.L., Guskiewicz K.M., Berger M.S., Kramer J.H., et al. Association of traumatic brain injury with subsequent neurological and psychiatric disease: A meta-analysis. J. Neurosurg. 2016;124:511&#x2013;526. doi: 10.3171/2015.2.JNS14503.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2015.2.JNS14503</ArticleId><ArticleId IdType="pmc">PMC4751029</ArticleId><ArticleId IdType="pubmed">26315003</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B., Fernandes N., Pulliam L. Profile of neuronal exosomes in HIV cognitive impairment exposes sex differences. Aids. 2019;33:1683&#x2013;1692. doi: 10.1097/QAD.0000000000002272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000002272</ArticleId><ArticleId IdType="pubmed">31149942</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Kido T., Shi J., McCafferty E., Ford J.M., Dal Bon K., Pulliam L. Blood Markers Show Neural Consequences of LongCOVID-19. Cells. 2024;13:478. doi: 10.3390/cells13060478.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells13060478</ArticleId><ArticleId IdType="pmc">PMC10969290</ArticleId><ArticleId IdType="pubmed">38534322</ArticleId></ArticleIdList></Reference><Reference><Citation>Griggs E., Trageser K., Naughton S., Yang E.J., Mathew B., Van Hyfte G., Hellmers L., Jette N., Estill M., Shen L., et al. Recapitulation of pathophysiological features of AD in SARS-CoV-2-infected subjects. eLife. 2023;12:e86333. doi: 10.7554/eLife.86333.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86333</ArticleId><ArticleId IdType="pmc">PMC10361716</ArticleId><ArticleId IdType="pubmed">37417740</ArticleId></ArticleIdList></Reference><Reference><Citation>Roczkowsky A., Limonta D., Fernandes J.P., Branton W.G., Clarke M., Hlavay B., Noyce R.S., Joseph J.T., Ogando N.S., Das S.K., et al. COVID-19 Induces Neuroinflammation and Suppresses Peroxisomes in the Brain. Ann. Neurol. 2023;94:531&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pubmed">37190821</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnicka-Dro&#x17c;ak E., Dro&#x17c;ak P., Mizerski G., Zaborowski T., &#x15a;lusarska B., Nowicki G., Dro&#x17c;ak M. Links between COVID-19 and Alzheimer&#x2019;s Disease&#x2014;What Do We Already Know? Int. J. Environ. Res. Public Health. 2023;20:2146. doi: 10.3390/ijerph20032146.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20032146</ArticleId><ArticleId IdType="pmc">PMC9915236</ArticleId><ArticleId IdType="pubmed">36767513</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocampo F.F., Promsena P., Chan P. Update on Central Nervous System Effects of the Intersection of HIV-1 and SARS-CoV-2. Curr. HIV/AIDS Rep. 2023;20:345&#x2013;356. doi: 10.1007/s11904-023-00676-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11904-023-00676-8</ArticleId><ArticleId IdType="pubmed">37950846</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijerathne H., Witek M.A., Jackson J.M., Brown V., Hupert M.L., Herrera K., Kramer C., Davidow A.E., Li Y., Baird A.E., et al. Affinity enrichment of extracellular vesicles from plasma reveals mRNA changes associated with acute ischemic stroke. Commun. Biol. 2020;3:613. doi: 10.1038/s42003-020-01336-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-020-01336-y</ArticleId><ArticleId IdType="pmc">PMC7589468</ArticleId><ArticleId IdType="pubmed">33106557</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ry C., Witwer K.W., Aikawa E., Alcaraz M.J., Anderson J.D., Andriantsitohaina R., Antoniou A., Arab T., Archer F., Atkin-Smith G.K., et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles. 2018;7:1535750. doi: 10.1080/20013078.2018.1535750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2018.1535750</ArticleId><ArticleId IdType="pmc">PMC6322352</ArticleId><ArticleId IdType="pubmed">30637094</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucien F., Gustafson D., Lenassi M., Li B., Teske J.J., Boilard E., von Hohenberg K.C., Falc&#xf3;n-Perez J.M., Gualerzi A., Reale A., et al. MIBlood-EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle research. J. Extracell. Vesicles. 2023;12:12385. doi: 10.1002/jev2.12385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12385</ArticleId><ArticleId IdType="pmc">PMC10704543</ArticleId><ArticleId IdType="pubmed">38063210</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Souza G., Bhondoekhan F., Benning L., Margolick J.B., Adedimeji A.A., Adimora A.A., Alcaide M.L., Cohen M.H., Detels R., Friedman M.R., et al. Characteristics of the MACS/WIHS Combined Cohort Study: Opportunities for Research on Aging with HIV in the Longest US Observational Study of HIV. Am. J. Epidemiol. 2021;190:1457&#x2013;1475. doi: 10.1093/aje/kwab050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwab050</ArticleId><ArticleId IdType="pmc">PMC8484936</ArticleId><ArticleId IdType="pubmed">33675224</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijerathne H., Witek M.A., Baird A.E., Soper S.A. Liquid biopsy markers for stroke diagnosis. Expert. Rev. Mol. Diagn. 2020;20:771&#x2013;788. doi: 10.1080/14737159.2020.1777859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737159.2020.1777859</ArticleId><ArticleId IdType="pmc">PMC8157911</ArticleId><ArticleId IdType="pubmed">32500751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellegaard Nielsen J., Sofie Pedersen K., Vesterg&#xe5;rd K., Georgiana Maltesen R., Christiansen G., Lundbye-Christensen S., Moos T., Risom Kristensen S., Pedersen S. Novel Blood-Derived Extracellular Vesicle-Based Biomarkers in Alzheimer&#x2019;s Disease Identified by Proximity Extension Assay. Biomedicines. 2020;8:199. doi: 10.3390/biomedicines8070199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8070199</ArticleId><ArticleId IdType="pmc">PMC7400538</ArticleId><ArticleId IdType="pubmed">32645971</ArticleId></ArticleIdList></Reference><Reference><Citation>You Y., Zhang Z., Sultana N., Ericsson M., Martens Y.A., Sun M., Kanekiyo T., Ikezu S., Shaffer S.A., Ikezu T. ATP1A3 as a target for isolating neuron-specific extracellular vesicles from human brain and biofluids. Sci. Adv. 2023;9:eadi3647. doi: 10.1126/sciadv.adi3647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.adi3647</ArticleId><ArticleId IdType="pmc">PMC10881047</ArticleId><ArticleId IdType="pubmed">37713494</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiandaca M.S., Kapogiannis D., Mapstone M., Boxer A., Eitan E., Schwartz J.B., Abner E.L., Petersen R.C., Federoff H.J., Miller B.L., et al. Identification of preclinical Alzheimer&#x2019;s disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimers Dement. 2015;11:600&#x2013;607.e1. doi: 10.1016/j.jalz.2014.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2014.06.008</ArticleId><ArticleId IdType="pmc">PMC4329112</ArticleId><ArticleId IdType="pubmed">25130657</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardar Sinha M., Ansell-Schultz A., Civitelli L., Hildesj&#xf6; C., Larsson M., Lannfelt L., Ingelsson M., Hallbeck M. Alzheimer&#x2019;s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. Acta Neuropathol. 2018;136:41&#x2013;56. doi: 10.1007/s00401-018-1868-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1868-1</ArticleId><ArticleId IdType="pmc">PMC6015111</ArticleId><ArticleId IdType="pubmed">29934873</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopatina O.L., Komleva Y.K., Malinovskaya N.A., Panina Y.A., Morgun A.V., Salmina A.B. CD157 and Brain Immune System in (Patho)physiological Conditions: Focus on Brain Plasticity. Front. Immunol. 2020;11:585294. doi: 10.3389/fimmu.2020.585294.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.585294</ArticleId><ArticleId IdType="pmc">PMC7693531</ArticleId><ArticleId IdType="pubmed">33304350</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortolan E., Augeri S., Fissolo G., Musso I., Funaro A. CD157: From immunoregulatory protein to potential therapeutic target. Immunol. Lett. 2019;205:59&#x2013;64. doi: 10.1016/j.imlet.2018.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2018.06.007</ArticleId><ArticleId IdType="pubmed">29936181</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopatina O., Yoshihara T., Nishimura T., Zhong J., Akther S., Fakhrul A.A., Liang M., Higashida C., Sumi K., Furuhara K., et al. Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson&#x2019;s disease. Front. Behav. Neurosci. 2014;8:133. doi: 10.3389/fnbeh.2014.00133.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnbeh.2014.00133</ArticleId><ArticleId IdType="pmc">PMC4001052</ArticleId><ArticleId IdType="pubmed">24795584</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno A., Cherepanov S.M., Kikuchi Y., Fakhrul A.A., Akther S., Deguchi K., Yoshihara T., Ishihara K., Shuto S., Higashida H. Lipo-oxytocin-1, a Novel Oxytocin Analog Conjugated with Two Palmitoyl Groups, Has Long-Lasting Effects on Anxiety-Related Behavior and Social Avoidance in CD157 Knockout Mice. Brain Sci. 2015;5:3&#x2013;13. doi: 10.3390/brainsci5010003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci5010003</ArticleId><ArticleId IdType="pmc">PMC4390788</ArticleId><ArticleId IdType="pubmed">25612002</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C., Lu W., Zhai L., Bethea T., Berry K., Qu Z., Waud W.R., Li Y. Mesd is a general inhibitor of different Wnt ligands in Wnt/LRP signaling and inhibits PC-3 tumor growth in vivo. FEBS Lett. 2011;585:3120&#x2013;3125. doi: 10.1016/j.febslet.2011.08.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2011.08.046</ArticleId><ArticleId IdType="pmc">PMC3183310</ArticleId><ArticleId IdType="pubmed">21907199</ArticleId></ArticleIdList></Reference><Reference><Citation>Arredondo S.B., Valenzuela-Bezanilla D., Mardones M.D., Varela-Nallar L. Role of Wnt Signaling in Adult Hippocampal Neurogenesis in Health and Disease. Front. Cell Dev. Biol. 2020;8:860. doi: 10.3389/fcell.2020.00860.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00860</ArticleId><ArticleId IdType="pmc">PMC7525004</ArticleId><ArticleId IdType="pubmed">33042988</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamada K., Shimozaki K., Chapoval A.I., Zhai Y., Su J., Chen S.-F., Hsieh S.-L., Nagata S., Ni J., Chen L. LIGHT, a TNF-Like Molecule, Costimulates T Cell Proliferation and Is Required for Dendritic Cell-Mediated Allogeneic T Cell Response1. J. Immunol. 2000;164:4105&#x2013;4110. doi: 10.4049/jimmunol.164.8.4105.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.164.8.4105</ArticleId><ArticleId IdType="pubmed">10754304</ArticleId></ArticleIdList></Reference><Reference><Citation>Clifford D.B., Ances B.M. HIV-associated neurocognitive disorder. Lancet Infect. Dis. 2013;13:976&#x2013;986. doi: 10.1016/S1473-3099(13)70269-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70269-X</ArticleId><ArticleId IdType="pmc">PMC4108270</ArticleId><ArticleId IdType="pubmed">24156898</ArticleId></ArticleIdList></Reference><Reference><Citation>Levone B.R., Cryan J.F., O&#x2019;Leary O.F. Role of adult hippocampal neurogenesis in stress resilience. Neurobiol. Stress. 2015;1:147&#x2013;155. doi: 10.1016/j.ynstr.2014.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ynstr.2014.11.003</ArticleId><ArticleId IdType="pmc">PMC4721321</ArticleId><ArticleId IdType="pubmed">27589664</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenfeld T.J., Gould E. Stress, stress hormones, and adult neurogenesis. Exp. Neurol. 2012;233:12&#x2013;21. doi: 10.1016/j.expneurol.2011.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2011.01.008</ArticleId><ArticleId IdType="pmc">PMC3715962</ArticleId><ArticleId IdType="pubmed">21281629</ArticleId></ArticleIdList></Reference><Reference><Citation>Petralia M.C., Battaglia G., Bruno V., Pennisi M., Mangano K., Lombardo S.D., Fagone P., Cavalli E., Saraceno A., Nicoletti F., et al. The Role of Macrophage Migration Inhibitory Factor in Alzheimer&#x2019;s Disease: Conventionally Pathogenetic or Unconventionally Protective? Molecules. 2020;25:291. doi: 10.3390/molecules25020291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25020291</ArticleId><ArticleId IdType="pmc">PMC7024279</ArticleId><ArticleId IdType="pubmed">31936865</ArticleId></ArticleIdList></Reference><Reference><Citation>Brosseron F., Kolbe C.-C., Santarelli F., Carvalho S., Antonell A., Castro-Gomez S., Tacik P., Namasivayam A.A., Mangone G., Schneider R., et al. Multicenter Alzheimer&#x2019;s and Parkinson&#x2019;s disease immune biomarker verification study. Alzheimer&#x2019;s Dement. 2019;16:292&#x2013;304. doi: 10.1016/j.jalz.2019.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.07.018</ArticleId><ArticleId IdType="pubmed">31630996</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacher M., Deuster O., Aljabari B., Egensperger R., Neff F., Jessen F., Popp J., Noelker C., Reese J.P., Al-Abed Y., et al. The Role of Macrophage Migration Inhibitory Factor in Alzheimer&#x2019;s Disease. Mol. Med. 2010;16:116&#x2013;121. doi: 10.2119/molmed.2009.00123.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2009.00123</ArticleId><ArticleId IdType="pmc">PMC2829616</ArticleId><ArticleId IdType="pubmed">20200619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Zhao J., Zhang Y., Zhang Y., Cai F., Wang L., Song W. Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer&#x2019;s disease. Alzheimers Res. Ther. 2019;11:54. doi: 10.1186/s13195-019-0508-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-019-0508-x</ArticleId><ArticleId IdType="pmc">PMC6555932</ArticleId><ArticleId IdType="pubmed">31174614</ArticleId></ArticleIdList></Reference><Reference><Citation>Hok A.H.Y.S., Del Campo M., Boiten W.A., Stoops E., Vanhooren M., Lemstra A.W., van der Flier W.M., Teunissen C.E. Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer&#x2019;s disease. J. Neuroinflammation. 2023;20:107. doi: 10.1186/s12974-023-02796-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-023-02796-9</ArticleId><ArticleId IdType="pmc">PMC10163795</ArticleId><ArticleId IdType="pubmed">37147668</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasiri E., Sankowski R., Dietrich H., Oikonomidi A., Huerta P.T., Popp J., Al-Abed Y., Bacher M. Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer&#x2019;s disease. Mol. Med. 2020;26:34. doi: 10.1186/s10020-020-00163-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-020-00163-5</ArticleId><ArticleId IdType="pmc">PMC7164357</ArticleId><ArticleId IdType="pubmed">32303185</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S.Q., Yu Y., Han J.Z., Wang D., Liu J., Qian F., Fan G.H., Bucala R., Ye R.D. Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer&#x2019;s disease. J. Neuroinflammation. 2015;12:177. doi: 10.1186/s12974-015-0396-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0396-3</ArticleId><ArticleId IdType="pmc">PMC4574615</ArticleId><ArticleId IdType="pubmed">26382037</ArticleId></ArticleIdList></Reference><Reference><Citation>Fancourt D., Steptoe A., Bu F. Psychological consequences of long COVID: Comparing trajectories of depressive and anxiety symptoms before and after contracting SARS-CoV-2 between matched long- and short-COVID groups. Br. J. Psychiatry. 2023;222:74&#x2013;81. doi: 10.1192/bjp.2022.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2022.155</ArticleId><ArticleId IdType="pmc">PMC7614126</ArticleId><ArticleId IdType="pubmed">36458509</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Xu J., Hou Y., Leverenz J.B., Kallianpur A., Mehra R., Liu Y., Yu H., Pieper A.A., Jehi L., et al. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. Alzheimers Res. Ther. 2021;13:110. doi: 10.1186/s13195-021-00850-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00850-3</ArticleId><ArticleId IdType="pmc">PMC8189279</ArticleId><ArticleId IdType="pubmed">34108016</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperling R.A., Aisen P.S., Beckett L.A., Bennett D.A., Craft S., Fagan A.M., Iwatsubo T., Jack C.R., Jr., Kaye J., Montine T.J., et al. Toward defining the preclinical stages of Alzheimer&#x2019;s disease: Recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimers Dement. 2011;7:280&#x2013;292. doi: 10.1016/j.jalz.2011.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.03.003</ArticleId><ArticleId IdType="pmc">PMC3220946</ArticleId><ArticleId IdType="pubmed">21514248</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw L.M., Vanderstichele H., Knapik-Czajka M., Clark C.M., Aisen P.S., Petersen R.C., Blennow K., Soares H., Simon A., Lewczuk P., et al. Cerebrospinal fluid biomarker signature in Alzheimer&#x2019;s disease neuroimaging initiative subjects. Ann. Neurol. 2009;65:403&#x2013;413. doi: 10.1002/ana.21610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21610</ArticleId><ArticleId IdType="pmc">PMC2696350</ArticleId><ArticleId IdType="pubmed">19296504</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullins R.J., Mustapic M., Chia C.W., Carlson O., Gulyani S., Tran J., Li Y., Mattson M.P., Resnick S., Egan J.M., et al. A Pilot Study of Exenatide Actions in Alzheimer&#x2019;s Disease. Curr. Alzheimer Res. 2019;16:741&#x2013;752. doi: 10.2174/1567205016666190913155950.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205016666190913155950</ArticleId><ArticleId IdType="pmc">PMC7476877</ArticleId><ArticleId IdType="pubmed">31518224</ArticleId></ArticleIdList></Reference><Reference><Citation>Pahattuge T.N., Jackson J.M., Digamber R., Wijerathne H., Brown V., Witek M.A., Perera C., Givens R.S., Peterson B.R., Soper S.A. Visible photorelease of liquid biopsy markers following microfluidic affinity-enrichment. Chem. Commun. 2020;56:4098&#x2013;4101. doi: 10.1039/C9CC09598E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9CC09598E</ArticleId><ArticleId IdType="pmc">PMC7469076</ArticleId><ArticleId IdType="pubmed">32163053</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ry C., Amigorena S., Raposo G., Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. 2006;30:3&#x2013;22. doi: 10.1002/0471143030.cb0322s30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471143030.cb0322s30</ArticleId><ArticleId IdType="pubmed">18228490</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Kirsch R., Koutrouli M., Nastou K., Mehryary F., Hachilif R., Gable A.L., Fang T., Doncheva N.T., Pyysalo S., et al. The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638&#x2013;D646. doi: 10.1093/nar/gkac1000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac1000</ArticleId><ArticleId IdType="pmc">PMC9825434</ArticleId><ArticleId IdType="pubmed">36370105</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498&#x2013;2504. doi: 10.1101/gr.1239303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. R Core Team; Vienna, Austria: 2023.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>